Research ArticleArticle
Assessing the Risk of Drug-Induced Cholestasis Using Unbound Intrahepatic Concentrations
Julia Riede, Birk Poller, Jörg Huwyler and Gian Camenisch
Drug Metabolism and Disposition May 2017, 45 (5) 523-531; DOI: https://doi.org/10.1124/dmd.116.074179
Julia Riede
Division of Drug Metabolism and Pharmacokinetics, Integrated Drug Disposition Section, Novartis Institutes for BioMedical Research, Basel, Switzerland (J.R., B.P., G.C.); and Department of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Basel, Switzerland (J.R., J.H.)
Birk Poller
Division of Drug Metabolism and Pharmacokinetics, Integrated Drug Disposition Section, Novartis Institutes for BioMedical Research, Basel, Switzerland (J.R., B.P., G.C.); and Department of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Basel, Switzerland (J.R., J.H.)
Jörg Huwyler
Division of Drug Metabolism and Pharmacokinetics, Integrated Drug Disposition Section, Novartis Institutes for BioMedical Research, Basel, Switzerland (J.R., B.P., G.C.); and Department of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Basel, Switzerland (J.R., J.H.)
Gian Camenisch
Division of Drug Metabolism and Pharmacokinetics, Integrated Drug Disposition Section, Novartis Institutes for BioMedical Research, Basel, Switzerland (J.R., B.P., G.C.); and Department of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Basel, Switzerland (J.R., J.H.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Unbound Intrahepatic Drug Concentrations Predict Cholestasis
Julia Riede, Birk Poller, Jörg Huwyler and Gian Camenisch
Drug Metabolism and Disposition May 1, 2017, 45 (5) 523-531; DOI: https://doi.org/10.1124/dmd.116.074179
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement